PHASERX, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0002 USD | -.--% |
|
-.--% | -.--% |
| 2019 | Roivant Sciences GmbH cancelled the acquisition of substantially all of the assets from PhaseRx, Inc. | CI |
| 2018 | PhaseRx, Inc. Bankruptcy Case Dismissed | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| PHASERX, INC. | Bio Therapeutic Drugs | -.--% | -.--% | -.--% | +100.00% | -95.56% | 2.34K | - | - | - |
Technical Rankings Surperformance
- Stock Market
- Equities
- PZRXQ Stock
- Charts PhaseRx, Inc.
- Comparison Chart
